CCA
PFE icon

Canyon Capital Advisors’s Pfizer PFE Stock Holding History

Canyon Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-834,825
Closed -$24.9M – 64
2015
Q3 		$24.9M Buy
834,825
+22,218
+3% +$712K 0.68% 39
2015
Q2 		$25.9M Buy
812,607
+205,503
+34% +$6.7M 0.68% 41
2015
Q1 		$20M Buy
+607,104
New +$19.3M 0.63% 40

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Canyon Capital Advisors's PFE Position: Q4 2015 in Review

Canyon Capital Advisors sold out of Pfizer (PFE) in Q4 2015, closing a stake of 834,825 shares — an estimated $24.9M sold.

Canyon Capital Advisors first reported a position in PFE in Q1 2015 and held it in 3 quarters. The position peaked at $25.9M in Q2 2015. 1,970 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

  • Canyon Capital Advisors reported no remaining Pfizer position as of Q4 2015 after selling out during the quarter.
  • Canyon Capital Advisors sold 834,825 Pfizer shares in Q4 2015, an estimated $24.9M.
  • Canyon Capital Advisors first reported a position in Pfizer in Q1 2015 and held it in 3 quarters.
  • Canyon Capital Advisors's Pfizer position peaked at $25.9M in Q2 2015.
  • 1,970 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Canyon Capital Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.